A detailed history of Jnba Financial Advisors transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Jnba Financial Advisors holds 12,000 shares of TLSA stock, worth $11,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,000
Previous 12,000 -0.0%
Holding current value
$11,160
Previous $11,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$0.55 - $0.85 $5,500 - $8,500
10,000 Added 500.0%
12,000 $6,000
Q1 2023

May 01, 2023

BUY
$0.51 - $1.1 $1,020 - $2,200
2,000 New
2,000 $2,000

Others Institutions Holding TLSA

About Tiziana Life Sciences Ltd


  • Ticker TLSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,273,000
  • Market Cap $95.1M
  • Description
  • Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...
More about TLSA
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.